E-MOTE group: Participants in the experimental group will receive the E-MOTE robot intervention on the first and second days after surgery. The intervention includes an emotional assessment, followed by appropriate dialogue modules tailored to the level of emotional distress. These are supplemented with emotion-generated empathetic conversations for deeper engagement, a session of self-affirmation relaxation training, and a subsequent Q\&A session.
Study summary
To develop the E-MOTE robot and evaluate its effectiveness in addressing psychological distress, physical symptom, stress index, and quality of life, as well as to explore its clinical applicability.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Stage 1 (For patients and nurse) \*\*\*Patients\*\*\*
Inclusion Criteria:
* Aged 18 years or older.
* Diagnosed with gynecologic cancer and undergoing surgery.
* Willing to receive E-MOTE robot and wear a smart wearable device.
* Willing to complete pre-test and post-test questionnaires.
Exclusion Criteria:
* Unable to communicate clearly.
* Unwilling or unable to participate in the study in its entirety.
\*\*\*Nurse\*\*\*
Inclusion Criteria:
* Aged 18 years or older.
* As a clinical nurse and has cared for patients who received the E-MOTE robot
Exclusion Criteria:
\- Unwilling to participate in the qualitative interview.
Stage 2 (only for patients) \*\*\*Intervention group\*\*\*
Inclusion Criteria:
* Aged 18 years or older.
* Diagnosed with gynecologic cancer and scheduled to undergo surgery.
* Willing to receiveE-MOTE robot and to wear a smart wearable device.
* Willing to complete pre-test and post-test questionnaires.
Exclusion Criteria:
* Unable to communicate clearly.
* Unwilling or unable to participate in the study in its entirety.
\*\*\*Control group\*\*\*
Inclusion Criteria:
* Aged 18 years or older.
* Diagnosed with gynecologic cancer and scheduled to undergo surgery.
* Willing to complete pre-test and post-test questionnaires.
Exclusion Criteria:
* Unable to communicate clearly.
* Unwilling or unable to participate in the study in its entirety.
Primary outcome measure(s)
Distress — Measurements will be taken before the intervention, three days after surgery, and one week after discharge. Investigators utilized the Distress Thermometer(DT) as the primary outcome measure. The scale uses a 11 Liker scale, where 0 indicates no distress at all and 10 represents the most severe distress.Higher score indicates a more severe distress. When the score is 4 or higher, a Problem List (PL) is used to further identify factors contributing to the emotional distress.
Depression — Measurements will be taken before the intervention, three days after surgery, and one week after discharge. Investigators utilized the Patient Health Questionnaire (PHQ-9) as the primary outcome measure to assess depression. The scale consists of 9 items, each rated on a 4-point Likert scale (0 = not at all, 3 = nearly every day). The total score ranges from 0 to 27, and depression severity can be categorized as mild (5-9), moderate (10-14), moderately severe (15-19), and severe (20 or above).Higher score indicates a more severe depression.
Trial sites (1)
Facility
City
Region
Status
National Taiwan University
Taipei
Taiwan
Recruiting
More National Taiwan University Hospital trials in Taiwan
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.
